Developing novel drugs for multiple cancers and other serious disorders1-10 Employees
Biscayne Pharmaceuticals careers
Biscayne Pharmaceuticals is developing novel drugs for cancer and other serious disorders based on analogs of growth hormone-releasing hormone (GHRH) discovered by Dr. Andrew V. Schally, Nobel laureate and renowned drug researcher.
Our extensive preclinical data package demonstrates that BIS-1602 disrupts a fundamental cancer pathway. We believe that a positive outcome in one cancer type will indicate proof of concept applicable to multiple cancers and that potential acquirers will appreciate that fact.
Our lead compound has inhibited the growth of many cancers (which represent 78% of all cancer deaths in 2012) in preclinical studies.
Our extensive preclinical data package demonstrates that BIS-1602 disrupts a fundamental cancer pathway. We believe that a positive outcome in one cancer type will indicate proof of concept applicable to multiple cancers and that potential acquirers will appreciate that fact.
Our lead compound has inhibited the growth of many cancers (which represent 78% of all cancer deaths in 2012) in preclinical studies.
Biscayne Pharmaceuticals hasn't added any jobs yet
Get notified when Biscayne Pharmaceuticals posts new jobs.
Samuel Reich
Founder @Biscayne Pharmaceuticals
Peter Goldstein
Founder Biscayne Pharmaceuticals Inc. • Studied at @University of Florida, @University of Miami
Jared Mendel
Co-founded Biscayne Nuero- sold to $SUPN in late 2018. Co-founded Stratford Cresson - investing in the intersection of litigation and healthcare receivables.
Total raised
$4.1M
Funded over
2 rounds
Latest round
May 2014
Syndax Pharmaceuticals • New York City • 2 days ago
Akebia Therapeutics • Oakland • $178k – $220k • 3 days ago
Wasatch Microfluidics • Indiana • 3 days ago
Ptc Therapeutics • New Jersey • $198k – $232k • 4 days ago
Fluidigm • Markham • $61k – $88k • 5 days ago